FDA Approved: NORVASC — Supplemental Application (Viatris Specialty LLC)

View source ↗

Summary

FDA approved a supplemental application for Norvasc (amlodipine besylate) submitted by Viatris Specialty LLC, resulting in an approved labeling action for the d…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Hypertension

Drugs mentioned

• NORVASC (amlodipine besylate)

Snippet

SUPPL AP for NORVASC (AMLODIPINE BESYLATE)